Description:

The ticker GMAB refers to Genmab A/S (GMAB), a biotechnology company listed on the New York Stock Exchange. Based in Copenhagen, Denmark, Genmab specializes in the creation and development of differentiated antibody therapeutics for the treatment of cancer. The company has established itself as a leader in the field through its innovative approach to developing monoclonal antibodies that target various types of cancers, contributing significantly to advancements in immunotherapy. Genmab collaborates with global pharmaceutical partners to bring its cutting-edge treatments to patients around the world, reflecting its commitment to improving patient outcomes and quality of life.

Data:

Yields: